Huaxin Duan - Concepedia

Author

Huaxin Duan

Hunan Provincial People's Hospital ORCID

Also Known As

H T Duan, Hua-Xin Duan, Hua-xin Duan, Huaxin Duan

Publications

428

Citations

H-Index

Concepts

All Affiliations

Hunan Provincial People's Hospital Hunan Normal University Central South University Sichuan Cancer Hospital Fudan University Shanghai Cancer Center

About

Huaxin Duan is an author at Hunan Provincial People's Hospital specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	146
2	Health Sciences	2	2	24
3	Cell Biology	2	2	87
4	Immunology	2	2	49
5	Hepatology	1	1	10

Huaxin Duan

Publications

350

Citations

H-Index

Page 1

	Year	Citations
LFA-1 and VLA-4 involved in human high proliferative potentialendothelial progenitor cells homing to ischemic tissue Huaxin Duan, Lamei Cheng, Xuan Sun, Thrombosis and Haemostasis	2006	53
Down-regulation of TCF21 by hypermethylation induces cell proliferation, migration and invasion in colorectal cancer Youyi Dai, Huaxin Duan, Chaojun Duan, Biochemical and Biophysical Research Communications Tumor BiologyOncologyEpigenetic RegulationMedicineOncogenic Agent	2015	52
MiR-193a-5p Targets the Coding Region of AP-2α mRNA and Induces Cisplatin Resistance in Bladder Cancers Ji Zhou, Huaxin Duan, Yu Xie, Journal of Cancer	2016	41
TCF21 functions as a tumor suppressor in colorectal cancer through inactivation of PI3K/AKT signaling Youyi Dai, Huaxin Duan, Chaojun Duan, OncoTargets and Therapy Cancer ResearchMedicineTcf21 FunctionsTcf21 MethylationPathology	2017	35
A phase Ib/II study of cadonilimab (PD-1/CTLA-4 bispecific antibody) plus anlotinib as first-line treatment in patients with advanced non-small cell lung cancer Bolin Chen, Wenxiu Yao, Xingya Li, British Journal of Cancer MedicineImmunologyBronchial NeoplasmImmune Checkpoint InhibitorFirst-line Treatment	2023	35
Knockdown of POLQ interferes the development and progression of hepatocellular carcinoma through regulating cell proliferation, apoptosis and migration Qi Pan, Lu Wang, Yu Liu, Cancer Cell International	2021	31
TCF21 inhibits tumor-associated angiogenesis and suppresses the growth of cholangiocarcinoma by targeting PI3K/Akt and ERK signaling Huaxin Duan, Bowen Li, Xin Hong Zhuang, American Journal of Physiology-Gastrointestinal and Liver Physiology	2019	29
MAEL contributes to gastric cancer progression by promoting ILKAP degradation Xing Zhang, Yichong Ning, Yuzhong Xiao, Oncotarget	2017	23
Downregulation of MCM8 expression restrains the malignant progression of cholangiocarcinoma Jingcheng Hao, Haimin Deng, Yang Yuan, Oncology Reports	2021	17
Safety and efficacy of DB-1303 in patients with advanced/metastatic solid tumors: A multicenter, open-label, first-in-human, phase 1/2a study. Kathleen N. Moore, Dhanusha Sabanathan, Yiqun Du, Journal of Clinical Oncology Her2 –Cancer ManagementImmunologyImmunotherapeuticsOncology	2023	14

Page 1